| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |